Advertisement
Research Article| Volume 29, ISSUE 1, P15-22, January 01, 1991

Phenylethylaminergic mechanisms in attention-deficit disorder

DOI:https://doi.org/10.1016/0006-3223(91)90207-3
Phenylethylaminergic mechanisms in attention-deficit disorder
Previous ArticleAcute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects
Next ArticleFluvoxamine versus desipramine: Comparative polysomnographic effects
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Urinary excretion (24-hr) of β-phenylethylamine (PEA), phenylacetic acid (PAA), phenylalanine (Phe), and p-tyrosine (Tyr), and plasma levels of PAA, Phe, and Tyr were examined in 18 normal children and 26 children diagnosed as having attention-deficit hyperactivity disorder (ADHD). The results indicated that urinary excretion (expressed per g of creatinine) of free and total PEA was significantly lower in the ADHD patients, and plasma levels of Phe and Tyr were also decreased in the ADHD subjects compared with the normal controls.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Baker G.B.
        • Rao T.S.
        • Coutts R.T.
        Electron-capture gas chromatographic analysis of β-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization.
        J Chromatogr Biomed Appl. 1986; 381: 211-217
        • Baker G.B.
        • Bieck P.
        • Antonin K.H.
        • Schick C.
        • van Muyden J.
        Urinary increase of β-phenylethylamine and phenylacetic acid in volunteer subjects treated with phenelzine.
        J Neurochem. 1989; 52 (Suppl): S155
        • Bornstein R.A.
        • Baker G.B.
        Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome.
        Int J Neurosci. 1988; 42: 113-120
        • Bornstein R.A.
        • Baker G.B.
        • Carroll A.
        • King G.
        • Ashton S.
        Phenylethylamine metabolism in Tourette's syndrome.
        J Neuropsychiatry Clin Neurosci. 1990; (in press)
        • Boulton A.A.
        Trace amines and the neurosciences: An overview.
        in: Boulton A.A. Baker G.B. Dewhurst W.G. Sandler M. Neurobiology of the Trace Amines. Humana Press, Clifton, NJ1984: 13-24
        • Boulton A.A.
        • Milward L.
        Separation, determination and quantitative analysis of urinary phenylethylamine.
        J Chromatogr. 1971; 57: 187-196
        • Cassens G.
        • Roffman M.
        • Kuruc A.
        • Orsulak P.H.
        • Schildkraut J.J.
        Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock.
        Science. 1980; 209: 1138-1139
        • Conners C.K.
        Symptom patterns in hyperkinetic, neurotic, and normal children.
        Child Dev. 1970; 41: 667-682
        • Davis B.A.
        Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.
        J Chromatogr. 1989; 466: 89-218
        • DeLisi L.E.
        • Murphy D.L.
        • Karoum F.
        • Mueller E.
        • Targum S.
        • Wyatt R.J.
        Phenylethylamine excretion in depression.
        Psychiatry Res. 1984; 13: 193-201
        • Eriksson T.
        • Carlsson A.
        β-adrenergic control of brain uptake of large neutral amino acids.
        Life Sci. 1988; 42: 1583-1589
        • Fischer E.
        • Heller B.
        • Miró A.H.
        β-phenylethylamine in human urine.
        Arzneim-Forsch. 1968; 18: 1486
        • Fuller N.J.
        • Elia M.
        Factors influencing the production of creatinine: Implications for the determination and interpretation of urinary creatine and creatinine in man.
        Clin Chim Acta. 1988; 175: 199-210
        • Gjerris A.
        • Gjerris F.
        • Soelberg-Sorensen P.
        • et al.
        Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentration at brain level?.
        Acta Neurochir (Wien). 1988; 91: 55-59
        • Jenner D.A.
        • Harrison G.A.
        • Prior I.A.M.
        • Deonetti D.L.
        • Fujimoto W.Y.
        24-h catecholamine excretion: Relationships with age and weight.
        Clin Chim Acta. 1987; 164: 17-25
        • Karoum F.
        • Potkin S.D.
        • Chuang L.W.
        • Murphy D.L.
        • Liebowitz M.
        • Wyatt R.J.
        Phenylacetic acid excretion in schizophrenia and depression: The origins of PAA in man.
        Biol Psychiatry. 1984; 19: 165-178
        • Karoum F.
        • Torrey E.F.
        • Murphy D.L.
        • Wyatt R.J.
        The origin, drug interaction, urine, plasma and CSF concentration of phenylacetic acid in normal and psychiatric patients.
        in: Boulton A.A. Baker G.B. Dewhurst W.G. Sandler M. Neurobiology of the Trace Amines. Humana Press, Clifton, NJ1984: 457-473
        • Kessler J.A.
        • Gordon E.K.
        • Reid J.L.
        • Kopin I.J.
        Homovanillic acid and 3-methoxy-4-hydroxyphenylethyleneglycol production by the monkey spinal cord.
        J Neurochem. 1976; 26: 1057-1061
        • Khan A.U.
        • Dekirmenjian H.
        Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
        Am J Psychiatry. 1981; 138: 108-110
        • Leckman J.F.
        • Maas J.W.
        • Redmond E.J.
        • Heninger G.R.
        Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) in man: Preliminary report.
        Life Sci. 1980; 26: 2179-2185
        • Linnoila M.
        • Ninan P.T.
        • Scheinin M.
        • et al.
        Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
        Arch Gen Psychiatry. 1983; 40: 1290-1294
        • Maas J.W.
        • Hattox S.E.
        • Greene N.M.
        • Landis D.H.
        3-Methoxy-4-hydroxyphenylethyleneglycol production by human brain in vivo.
        Science. 1979; 205: 1025-1027
        • Markianos E.
        • Beckmann H.
        Diurnal changes in dopamine β-hydroxylase, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol in serum of man.
        J Neural Transm. 1976; 39: 79-93
        • Pardridge W.M.
        Regulation of amino acid availability to the brain.
        in: Nutrition and the Brain. vol 1. Raven Press, New York1977
        • Philips S.R.
        • Boulton A.A.
        The effects of monoamine oxidase inhibitors on some arylalkylamines in rat striatum.
        J Neurochem. 1979; 33: 159-167
        • Philips S.R.
        • Baker G.B.
        • McKim H.R.
        Effects of tranylcypromine on the concentration of some trace amines in the diencephalon and hippocampus of the rat.
        Experientia. 1980; 36: 241-242
        • Potkin S.G.
        • Karoum F.
        • Chuang L.-W.
        • Cannon-Spoor H.E.
        • Phillips I.
        • Wyatt R.J.
        Phenylethylamine in chronic paranoid schizophrenia.
        Science. 1979; 206: 470-471
        • Raiteri M.
        • del Carmine R.
        • Bertollini A.
        • Levi G.
        Effects of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
        Eur J Pharmacol. 1977; 41: 133-143
        • Rogeness G.A.
        • Maas J.W.
        • Javors M.A.
        • Macedo C.A.
        • Fischer C.
        • Harris W.R.
        Attention deficit disorder symptoms and urine catecholamines.
        Psychiatry Res. 1989; 27: 241-251
        • Sabelli H.C.
        • Mosnaim A.D.
        Phenylethylamine hypothesis of affective behaviour.
        Am J Psychiatry. 1974; 131: 695-699
        • Sabelli H.C.
        • Fawcett J.
        • Gusovsky F.
        • et al.
        Clinical studies on the phenylethylamine hypothesis of affective disorder: Urine and blood phenylacetic acid and phenylalanine dietary supplements.
        J Clin Psychiatry. 1986; 47: 66-70
        • Semba J.I.
        • Nankai M.
        • Maruyama Y.
        • Kaneno S.
        • Watanabe A.
        • Takahashi R.
        Increase in urinary β-phenylethylamine preceding the switch from mania to depression: A “rapid cycler”.
        J Nerv Ment Dis. 1988; 176: 116-119
        • Shekim W.O.
        • Javaid J.
        • Dekirmenjian H.
        • Chapel J.L.
        • Davis J.M.
        Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
        Am J Psychiatry. 1982; 139: 485-488
        • Shekim W.O.
        • Javaid J.
        • Davis J.M.
        • Bylund D.B.
        Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
        Biol Psychiatry. 1983; 18: 707-714
        • Szymanski H.V.
        • Naylor E.W.
        • Karoum F.
        Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.
        Biol Psychiatry. 1987; 22: 194-198
      36. Usdin E. Sandler M. Trace Amines and The Brain. Marcel Dekker, New York1976
        • Wong J.T.F.
        • Baker G.B.
        • Coutts P.T.
        Rapid and simple procedure for the determination of urinary phenylacetic acid using derivatization in aqueous medium followed by electron-capture gas chromatography.
        J Chromatogr Biomed Appl. 1988; 428: 140-146
        • Wood D.R.
        • Reimherr F.W.
        • Wender P.H.
        Treatment of attention deficit disorder with dl-phenylalanine.
        Psychiatry Res. 1985; 16: 21-26
        • Yeung J.M.
        • Baker G.B.
        • Coutts R.T.
        A simple automated gas chromatographic analysis of amino acids and its application to brain tissue and urine.
        J Chromatogr Biomed Appl. 1986; 378: 293-304
        • Yoshimoto S.
        • Kaku H.
        • Shimogawa S.
        • Watanabe A.
        • Nakagawara M.
        • Takahashi R.
        Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
        Psychiatry Res. 1987; 21: 229-236
        • Yu P.H.
        • Davis B.A.
        • Durden D.A.
        • et al.
        Further studies on platelet monoamine oxidase and penosulfotransferase and plasma levels of acid metabolites in aggressive and non-aggressive prisoners and children with attention deficit disorder.
        in: Boulton A.A. Maitre L. Bieck P.R. Riederer P. Neuropsychopharmacology of the Trace Amines. Humana Press, Clifton, NJ1985
        • Zametkin A.J.
        • Brown G.L.
        • Karoum F.
        • et al.
        Urinary phenylethylamine response to d-amphetamine in 12 boys with attention deficit disorder.
        Am J Psychiatry. 1984; 141: 1055-1058
        • Zametkin A.J.
        • Karoum F.
        • Rapoport J.L.
        • Brown G.L.
        • Wyatt R.J.
        Phenylethylamine excretion in attention deficit disorder.
        J Am Acad Child Psychiatry. 1984; 23: 310-314
        • Zametkin A.J.
        • Rapoport J.L.
        • Murphy D.T.
        • Ismond D.
        Treatment of hyperactive children with monoamine oxidase inhibitors: I. Clinical efficacy.
        Arch Gen Psychiatry. 1985; 42: 962-967
        • Zametkin A.J.
        • Linnoila M.
        • Karoum F.
        • Sallee R.
        Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
        Am J Psychiatry. 1986; 143: 359-362
        • Zametkin A.J.
        • Karoum F.
        • Ropoport J.L.
        Treatment of hyperactive children with d-phenylalanine.
        Am J Psychiatry. 1987; 144: 792-794

      Article info

      Publication history

      Received in revised form: June 1, 1990
      Received: January 15, 1990

      Identification

      DOI: https://doi.org/10.1016/0006-3223(91)90207-3

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX